Medtronic Lawsuit over Bone Growth Protein Product

The family of a California woman who died after neck surgery has sued Medtronic and blamed the company for the woman’s death. At the center of the lawsuit, Medtronic’s Infuse Bone Graft, is already under federal investigation for Medtronic’s possible illegal marketing of the product. Federal officials are investigating to determine if Medtronic was promoting the protein product for uses which the FDA did not approve.
According to the Wall St. Journal, “Use of Infuse in the neck is one of these so-called off-label uses. The only type of spine surgery for which Infuse has been approved is a frontal approach to the lower backbone, known as the lumbar spine.”